CHIP and mosaic chromosome alterations linked to frailty in 730,088 people
In four large cohorts, clonal hematopoiesis of indeterminate potential and autosomal mosaic chromosomal alterations were associated with frailty; mosaic loss of chromosome X or Y was not. Mouse and human T-cell findings suggest a possible immune pathway. [1]
Automatic summary · not editorially reviewed
The key findings
In 730,088 participants from four cohorts, CHIP and autosomal mosaic chromosomal alterations were strongly associated with frailty, while mosaic loss of chromosome X or Y was not. [1]
A Tet2 mouse model showed frailty-like functional decline across multiple organ systems, and in humans T-cell activation-related proteins mediated the association. [1]
The authors propose that clonal hematopoiesis accelerates biological aging through immunosenescence, a proposed model rather than a demonstrated cause in humans. [1]
The source at a glance
- Study type / format
- Observational cohort study with a mouse model (abstract)
- Population / context
- 730,088 participants from UK Biobank, All of Us, BioVU and the Women's Health Initiative, plus a Tet2 mouse model.
- Summary based on
- Study abstract
- Publication status
- Preprint · peer-review status not confirmed
- Original publication
- October 1, 2026
Frailty and blood mutations in four cohorts
The authors asked whether somatic mutations in blood were associated with new frailty and faster progression. They studied 730,088 participants from UK Biobank, All of Us, BioVU and the Women's Health Initiative. Clonal hematopoiesis of indeterminate potential (CHIP) means blood stem cells carry mutations without a diagnosed blood disease. CHIP and autosomal mosaic chromosomal alterations showed strong associations with frailty. Mosaic loss of chromosome X or Y did not. Results were consistent across survey-based, directly measured and clinically assessed frailty and healthspan measures.
Supporting source [1]
Mouse model and T-cell proteins in the human link
A Tet2 mouse model showed frailty-like functional decline across multiple organ systems and remodeling of T cells. In humans, proteins related to T-cell activation directly mediated the association between clonal hematopoiesis and frailty. The authors interpret this as support for a model in which clonal hematopoiesis accelerates biological aging through immunosenescence, the aging of the immune system. These are proposed mechanisms, not proof that the mutations cause frailty in people.
Supporting source [1]
Abstract-only scope of the CHIP frailty findings
Only the abstract was reviewed; the full text was not reviewed. The abstract reports associations in observational cohorts, so it does not establish that CHIP causes frailty. It gives no details on follow-up length, how frailty was scored, or adjustment for other factors. The mouse and T-cell results are supporting evidence, not human lifespan benefits.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Associations in observational cohorts do not show causation. Follow-up, frailty scoring and adjustment details are not reported. Mouse and T-cell findings are not human lifespan benefits.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Zhao K, Quin C, Pershad Y, Xue L, Cao W, Bowman GI, Vlasschaert C, Corty RW, Heimlich JB, DeJong EN, Lee C, Patel Z, Buttigieg MM, Verschoor CP, Bane CA, McNaughton AJ, Bowdish DM, Kuchel GA, Whitsel EA, Shadyab AH, Kooperberg C, LaCroix AZ, Reiner AP, Rauh MJ, Evans LM, Bick AG. · europepmc.org · October 1, 2026